Spinal Anesthesia - continued
Summary Ever since the introduction of local anesthetics, physicians have investigated different methods of using them. Spinal anesthesia has enjoyed a long and successful history since the late nineteenth century and is currently more popular than ever. Mastery of spinal anesthesia comes with practice; diligence; and knowledge of physiology, pharmacology, and anatomy. Patient safety must always be at the forefront when considering performing a spinal anesthetic. The ease of performance and versatility of spinal anesthesia will continue to result in its widespread popularity in both hospital and ambulatory surgical applications. REFERENCES: 1. Koller C: Vorlaufige Mittheilung ¨uber locale Anasthesirung am Auge. Klin Mbl Augenheilk 1884;22:60–63. 2. Halsted WS: Practical comments on the use and abuse of cocaine; suggested by its invariably successful employment in more than a thousand minor surgical operations. NY Med J 1885;42:294. 3. Corning JL: Spinal anaesthesia and local medication of the cord. NY Med J 1885;42:483–485. 4. Gorelick PB, Zych D: James Leonard Corning and the early history of spinal puncture. Neurology 1987;37:672–674. 5. Wynter E: Four cases of tubercular meningitis inwhich paracentesis of the theca vertebralis was performed for relief of fluid pressure. Lancet 1891:981–982. 6. Ball C, Westhorpe R: Local anaesthesia—Early spinal anaesthesia. Anaesth Intensive Care 2003;31:493. 7. Bier A: Experiments regarding the cocainization of the spinal cord. Dtsch Z Chir 1899;51:361–369. 8. Marx GF: The first spinal anesthesia.Who deserves the laurels? Reg Anesth 1994;19:429–430. 9. Wulf HF: The centennial of spinal anesthesia. Anesthesiology 1998;89:500–506. 10. Larson MD: Tait and Caglieri: The First Spinal Anesthetic in America. Anesthesiology 1996;85:913–919. 11. Matas R: Local and regional anesthesiawith cocaine and other analgesic drugs, including the subarachnoid method, as applied in the general surgical practice. Phil Med J 1900;6:820–843. 12. Vandam LD: On the origins of intrathecal anesthesia. Reg Anesth Pain Med 1998;23:335–339. 13. Tuffier T: Anesthesie medullaire chirurgicale par injection sousarachnoidienne lombaire de cocaine; technique et resultats. Sem Med 1900;20:167. 14. Barker AE: A report on clinical experiences with spinal analgesia in 100 cases and some reflections on the procedure. BMJ 1907;1:665– 674. 15. Labat G: Circulatory disturbances associated with subarachnoid nerve block. Long Island Med J 1927;21:573. 16. Pitkin G: Controllable spinal anesthesia. Am J Surg 1928;5:537. 17. Sise LF: Spinal anesthesia for upper and lower abdominal operations. N Engl J Med 1928;199:61. 18. Sise LF: Pontocainglucose for spinal anesthesia. Surg Clin North Am 1935;15:1501. 19. Brown DL, Fink BR: The history of neural blockade and pain management. In Cousins MJ, Bridenbaugh PO (eds): Neural Blockade, 3rd ed. Lippincott-Raven, 1998, pp 3–27. 20. Adriani J, Roman-Vega D: Saddle block anesthesia. Am J Surg 1946;71:12. 21. Dripps RD, Vandam LD: Long-term follow-up of patients who received 10,098 spinal anesthetics: failure to discover major neurologic sequelae. JAMA 1954;156:1486–1491. 22. Greene HM: Lumbar puncture and the prevention of postdural puncture headache. JAMA 1926;86:391–392. 23. Greene BA:A26 gauge lumbar puncture needle: Its value in the prophylaxis of headache following spinal analgesia for vaginal delivery. Anesthesiology 1950;11:464–469. 24. Hart JR, Whitacre RJ: Pencil-point needle in prevention of postspinal headache. JAMA 1951;147:657–658. 25. SprotteG, Schedel R,Pajunk H, et:An“atraumatic” universal needle for single-shot regional anesthesia: Clinical results and a 6 year trial in over 30,000 regional anesthesias. Reg Anaesth 1987;10:104–108. 26. Calthorpe N: The history of spinal needles: Getting to the point. Anaesthesia 2004;59:1231–1241. 27. Bamford C, Sibley W, Laguna J: Anesthesia in multiple sclerosis. Can J Neurol Sci 1978;5:41–44. 28. Kytta J, Rosenberg PH: Anaesthesia for patients with multiple sclerosis. Ann Chir Gynaecol 1984;73:299–303. 29. Bouchard P, Caillet JB, Monnet F, et al: Spinal anesthesia and multiple sclerosis. Ann Fr Anesth Reanim 1984;3:194–198. 30. Levesque P,Marsepoil T, Ho P, et al:Multiple sclerosis disclosed by spinal anesthesia. Ann Fr Anesth Reanim 1988;7: 68–70. 31. Vadalouca A, Moka E, Sykiotis C: Combined spinal-epidural technique for total hysterectomy in a patientwith advanced, progressive multiple sclerosis. Reg Anesth Pain Med 2002;27:540–541. 32. Thompson RC, Liberthson RR, Lowenstein E: Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy. JAMA 1985;254:2419–2421. 33. Loubser P, Suh K, Cohen S: Adverse effects of spinal anesthesia in a patient with idiopathic hypertrophic subaortic stenosis. Anesth Analg 1984;60:228–230. 34. McDonald SB: Is neuraxial blockade contraindicated in the patient with aortic stenosis? Reg Anesth Pain Med 2004;29:496–502. 35. O’Keefe JHJr, Shub C, Rettke SR: Risk of noncardiac surgical procedures in patients with aortic stenosis.Mayo Clin Proc 1989;64:400– 405. 36. Collard CD, Eappen S, Lynch EP, et al: Continuous spinal anesthesia with invasive hemodynamic monitoring for surgical repair of the hip in two patients with severe aortic stenosis. Anesth Analg 1995;81:195–198. 37. Reiman A, Anson B: Vertebral termination of the spinal cord with report of a case of sacral cord. Anat Rec 1944;88:127. 38. Bromage PR: Neurological complications of subarachnoid and epidural anaesthesia. Acta Anaesthesiol Scand 1997;41:439–444. 39. Covino B: Pharmacology of local anaesthetic agents. Br J Anaesth 1986;58:701–716. 40. Greene NM: Uptake and elimination of local anesthetics during spinal anesthesia. Anesth Analg 1983;62:1013–1024. 41. Stienstra R, Greene NM: Factors affecting the subarachnoid spread of local anesthetic solutions. Reg Anesth 1991;16:1–6. 42. Cohen EN: Distribution of local anesthetic agents in the neuraxis of the dog. Anesthesiology 1968;29:1002–1005. 43. Schell RM, Brauer FS, Cole DJ, et al: Persistent sacral nerve root deficits after continuous spinal anaesthesia. Can J Anaesth 1991;38:908–911. 44. Hogan Q: Size of human lower thoracic and lumbosacral nerve roots. Anesthesiology 1996;85:37–42. 45. Kaneko S, Matsumoto M, Tsuruta S, et al: The nerve root entry zone is highly vulnerable to intrathecal tetracaine in rabbits. Anesth Analg 2005;101:107–114. 46. Takenami T, Yagishita S, Asato F, et al: Neurotoxicity of intrathecally administered tetracaine commences at the posterior roots near entry into the spinal cord. Reg Anesth Pain Med 2000;25:372– 379. 47. Kristensen JD, Karlsten R, Gordh T: Spinal cord blood flow after intrathecal injection of ropivacaine and bupivacaine with or without epinephrine in rats. Acta Anaesthesiol Scand 1998;42:685–690. 48. Dohi S, Matsumiya N, Takeshima R, et al: The effects of subarachnoid lidocaine and phenylephrine on spinal cord and cerebral blood flow in dogs. Anesthesiology 1984;61:238–244. 49. Kozody R, Palahniuk RJ, Cumming MO: Spinal cord blood flow following subarachnoid tetracaine. Can Anaesth Soc J 1985;32:23–29. 50. Greene NM: Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg 1985;64:715–730. 51. Horlocker TT, Wedel DJ: Density, specific gravity, and baricity of spinal anesthetic solutions at body temperature. Anesth Analg 1993;76:1015–1018. 52. Hallworth SP, Fernando R, ColumbMO, et al: The effect of posture and baricity on the spread of intrathecal bupivacaine for elective cesarean delivery. Anesth Analg 2005;100:1159–1165. 53. McLeod GA: Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine, and ropivacaine with and without dextrose. Br J Anaesth 2004;92:547–551. 54. Brown DT, Wildsmith JA, Covino BG, et al: Effect of baricity on spinal anaesthesia with amethocaine. Br J Anaesth 1980;52:589–596. 55. Siker ES, Wolfson B, Stewart WD, et al: Mepivacaine for spinal anesthesia: Effects of changes in concentration and baricity. Anesth Analg 1966;45:191–196. 56. ChambersWA, Edstrom HH, Scott DB: Effect of baricity on spinal anaesthesia with bupivacaine. Br J Anaesth 1981;53:279–282. 57. DensonDD, Bridenbaugh PO,Turner PA, et al:Comparison of neural blockade and pharmacokinetics after subarachnoid lidocaine in the rhesus monkey. II: Effects of volume, osmolality, and baricity. Anesth Analg 1983;62:995–1001. 58. Hare GM, Ngan JC: Density determination of local anaesthetic opioid mixtures for spinal anaesthesia. Can J Anaesth 1998;45:341–346. 59. BodilyMN,Carpenter RL,Owens BD: Lidocaine 0.5% spinal anaesthesia: A hypobaric solution for short-stay perirectal surgery. Can J Anaesth 1992;39:770–773. 60. Lui AC, Polis TZ, Cicutti NJ: Densities of cerebrospinal fluid and spinal anaesthetic solutions in surgical patients at body temperature. Can J Anaesth 1998;45:297–303. 61. Sheskey MC, Rocco AG, Bizzari-Schmid M, et al: A doseresponse study of bupivacaine for spinal anesthesia. Anesth Analg 1983;62:931–935. 62. Hogan QH, Prost R, Kulier A, et al:Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure. Anesthesiology 1996;84: 1341–1349. 63. Carpenter RL, Hogan QH, Liu SS, et al: Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia. Anesthesiology 1998;89: 24–29. 64. Higuchi H, Hirata J, Adachi Y, et al: Influence of lumbosacral cerebrospinal fluid density, velocity, and volume on extent and duration of plain bupivacaine and spinal anesthesia. Anesthesiology 2004;100:106–114. 65. Schneider M, Ettlin T, Kaufmann M, et al: Transient neurologic toxicity afterhyperbaric anesthesiawith5%lidocaine.AnesthAnalg 1993;76:1154–1157. 66. Zaric D, Christiansen C, Pace NL, et al: Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: Asystematic review of randomized, controlled trials.Anesth 67. Zaric D, Christiansen C, Pace NL, et al: Transient neurologic symptoms(TNS)following spinal anaesthesiawith lidocaine versus other local anaesthetics. Cochrane Database Syst Rev 2005;100:1811–1816. 68. Hampl KF, Schneider MC, UmmenhoferW, et al: Transient neurologic symptomsafter spinal anesthesia.AnesthAnalg 1995;81:1148–1153. 69. Hampl KF, Heinzmann-Wiedmer S, Luginbuehl I, et al: Transient neurologic symptoms after spinal anesthesia: A lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology 1998;88:629–633. 70. Keld DB, Hein L, Dalgaard M, et al: The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand 2000;44:285–290. 71. Freedman JM, Li DK, Drasner K, et al: Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1,863 patients. Anesthesiology 1998; 89: 633–41. 72. Sumi M, Sakura S,Kosaka Y: Intrathecal hyperbaric 0.5% tetracaine as a possible cause of transient neurologic toxicity. Anesth Analg 1996; 82: 1076–7. 73. Sakura S, Sumi M, Sakaguchi Y, et al: The addition of phenylephrine contributes to the development of transient neurologic symptoms after spinal anesthesia with 0.5% tetracaine. Anesthesiology 1997;87:771–778. 74. Liguori GA, Zayas VM, Chisholm MF: Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine. Anesthesiology 1998;88:619–623. 75. Salazar F, Bogdanovich A, Adalia R, et al: Transient neurologic symptoms after spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine. Acta Anaesthesiol Scand 2001;45:240–245. 76. Eberhart LH, Morin AM, Kranke P, et al: Transient neurologic symptoms after spinal anesthesia. A quantitative systematic overview (meta-analysis) of randomized controlled studies. Anaesthesist 2002;51:539–546. 77. Ganapathy S, Sandhu HB, Stockall CA, et al: Transient neurologic symptom(TNS) following intrathecal ropivacaine. Anesthesiology 2000;93:1537–1539. 78. Buckenmaier CC 3rd, Nielsen KC, Pietrobon R, et al: Small-dose intrathecal lidocaine versus ropivacaine for anorectal surgery in an ambulatory setting. Anesth Analg 2002;95:1253–1257. 79. BreebaartMB, VercauterenMP, Hoffmann VL, et al: Urinary bladder scanning after day-case arthroscopy under spinal anaesthesia: Comparison between lidocaine, ropivacaine, and levobupivacaine. Br J Anaesth 2003;90:309–313. 80. Bridenbaugh PO,GreeneNM,Brull SJ: Spinal (subarachoid) neural blockade. In Cousins MJ, Bridenbaugh PO (eds): Neural Blockade, 3rd ed. Lippincott-Raven, 1998. 81. Brown DL: Spinal, Epidural, and Caudal Anesthesia. In Miller RD (ed): Anesthesia, 4th ed. Churchill Livingston, 1994, pp 1505–1533. 82. Pawlowski J, Sukhani R, Pappas AL, et al: The anesthetic and recovery profile of two doses (60 and 80 mg) of plain mepivacaine for ambulatory spinal anesthesia. Anesth Analg 2000;91:580–584. 83. Kallio H, Snall EV, KeroMP, et al: A comparison of intrathecal plain solutions containing ropivacaine 20 or 15 mg versus bupivacaine 10 mg. Anesth Analg 2004;99:713–717. 84. McNamee DA, Parks L, McClelland AM, et al: Intrathecal ropivacaine for total hip arthroplasty: Double-blind comparative study with isobaric 7.5 mg/mL and 10 mg/mL solutions. Br J Anaesth 2001;87:743–747. 85. Burke D, Kennedy S, Bannister J: Spinal anesthesia with 0.5% S(–)-bupivacaine for elective lower limb surgery. Reg Anesth Pain Med 1999;24:519–523. 86. Glaser C, Marhofer P, Zimpfer G, et al: Levobupivacaine versus racemic bupivacaine for spinal anesthesia. Anesth Analg 2002;94:194–198. 87. Alley EA, Kopacz DJ, McDonald SB, et al: Hyperbaric spinal levobupivacaine: A comparison to racemic bupivacaine in volunteers. Anesth Analg 2002;94:188–193. 88. Smith KN, Kopacz DJ, McDonald SB: Spinal 2-chloroprocaine: A dose-ranging study and the effect of added epinephrine. Anesth Analg 2004;9:81–88. 89. Tetzlaff JE, Dilger J, Yap E, et al: Cauda equina syndrome after spinal anaesthesia in a patient with severe vascular disease. Can J Anaesth 1998;45:667–669. 90. Lee DS, Bui T, Ferrarese J, et al: Cauda equina syndrome after incidental total spinal anesthesia with 2% lidocaine. J Clin Anesth 1998;10:66–69 91. Maehara Y, Kusunoki S, Kawamoto M, et al: A prospective multicenter trial to determine the incidence of transient neurologic symptomsafter spinal anesthesiawith phenylephrine added to 0.5% tetracaine. Hiroshima J Med Sci 2001;50:47–51. 92. Kozody R, Palahniuk RJ,Wade JG, et al: The effect of subarachnoid epinephrine and phenylephrine on spinal cord blood flow. Can Anaesth Soc J 1984;31:503–508. 93. Porter SS, Albin MS, Watson WA, et al: Spinal cord and cerebral blood flow responses to subarachnoid injection of local anesthetics with and without epinephrine. Acta Anaesthesiol Scand 1985;29:330–338. 94. Concepcion M, Maddi R, Francis D, et al: Vasoconstrictors in spinal anesthesia with tetracaine—A comparison of epinephrineand phenylephrine. Anesth Analg 1984;63:134–138. 95. Armstrong IR, Littlewood DG, Chambers WA: Spinal anesthesia with tetracaine—Effect of added vasoconstrictors. Anesth Analg 1983;62:793–795. 96. Rice LJ,DeMars PD,Whalen TV, et al: Duration of spinal anesthesia in infants less than one year of age. Comparison of three hyperbaric techniques. Reg Anesth 1994;19:325–329. 97. Chambers WA, Littlewood DG, Scott DB: Spinal anesthesia with hyperbaric bupivacaine: effect of added vasoconstrictors. Anesth Analg 1982;61:49–52. 98. Moore JM, Liu SS, Pollock JE, et al: The effect of epinephrine on small-dose hyperbaric bupivacaine spinal anesthesia: Clinical implications for ambulatory surgery. Anesth Analg 1998;86:973–977. 99. Racle JP, Poy JY, Benkhadra A, et al: Prolongation of spinal anesthesia with hyperbaric bupivacaine by adrenaline and clonidine in the elderly. Ann Fr Anesth Reanim 1988;7:139–144. 100. Vercauteren MP, Jacobs S, Jacquemyn Y, et al: Intrathecal labor analgesia with bupivacaine and sufentanil: the effect of adding 2.25 micrograms of epinephrine. Reg Anesth Pain Med 2001;26:473–477. 101. Goodman SR, Kim-Lo SH, Ciliberto CF, et al: Epinephrine is not a useful addition to intrathecal fentanyl or fentanyl-bupivacaine for labor analgesia. Reg Anesth Pain Med 2002;27:374–379. 102. Gautier PE, Debry F, Fanard L, et al: Ambulatory combined spinal-epidural analgesia for labor. Influence of epinephrine on bupivacaine-sufentanil combination. Reg Anesth 1997;22:143–149. 103. Chambers WA, Littlewood DG, Logan MR, et al: Effect of added epinephrine on spinal anesthesia with lidocaine. Anesth Analg 1981;60:417–420. 104. Chiu AA, Liu S, Carpenter RL, et al: The effects of epinephrine on lidocaine spinal anesthesia: A cross-over study. Anesth Analg 1995;80:735–739. 105. Racle JP, Benkhadra A, Poy JY: Subarachnoid anaesthesia produced by hyperbaric lignocaine in elderly patients. Prolongation of effect with adrenaline. Br J Anaesth 1988;60:831–835. 106. Spivey DL: Epinephrine does not prolong lidocaine spinal anesthesia in term parturients. Anesth Analg 1985;64:468–470. 107. Moore DC, Chadwick HS, Ready LB: Epinephrine prolongs lidocaine spinal: Pain in the operative site the most accurate method of determining local anesthetic duration. Anesthesiology 1987;67:416–418. 108. Glynn CJ,Mather LE, Cousins MJ, et al: Spinal narcotics and respiratory depression. Lancet 1979;2:356–357. 109. Cunningham AJ, McKenna JA, Skene DS: Single injection spinal anaesthesia with amethocaine and morphine for transurethral prostatectomy. Br J Anaesth 198355;:423–427. 110. Nordberg G,Hedner T,Mellstrand T, et al: Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984;60:448–454. 111. Abouleish E, Rawal N, Rashad MN: The addition of 0.2 mg subarachnoid morphine to hyperbaric bupivacaine for cesarean delivery: A prospective study of 856 cases. Reg Anesth 1991;16:137–140. 112. Borgeat A, Singer T: Nausea and vomiting after spinal anaesthesia with morphine. Acta Anaesthesiol Scand 1998;42:1231. 113. Bonnet F, BuissonVB, Francois Y, et al: Effects of oral and subarachnoid clonidine on spinal anesthesia with bupivacaine. Reg Anesth 1990;15:211–214. 114. Dobrydnjov I, Axelsson K, Thorn SE, et al: Clonidine combined with small-dose bupivacaine during spinal anesthesia for inguinal herniorrhaphy: A randomized double-blinded study. Anesth Analg 2003;96:1496–503. 115. Strebel S, Gurzeler JA, Schneider MC, et al: Small-dose intrathecal clonidine and isobaric bupivacaine for orthopedic surgery: A doseresponse study. Anesth Analg 2004;99:1231–1238. 116. Filos KS, Goudas LC, Patroni O, et al: Hemodynamic and analgesic profile after intrathecal clonidine in humans:Adose response study. Anesthesiology 1994;81:591–601. 117. Hassenbusch SJ, Gunes S,Wachsman S, et al: Intrathecal clonidine in the treatment of intractable pain: A phase I/II study. Pain Med 2002;3:85–91. 118. Ackerman LL, Follett KA, Rosenquist RW: Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage 2003;26:668–77. 119. Chen SR, Khan GM, Pan HL: Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathy. Anesthesiology 2001;95:1007–1012. 120. Ho KM, Ismail H, LeeKC, et al:Use of intrathecal neostigmine as an adjunct to other spinal medications in perioperative and peripartum analgesia:Ameta-analysis.Anaesth Intensive Care 2005;33:41–53. 121. Yegin A, Yilmaz M, Karsli B, et al: Analgesic effects of intrathecal neostigmine in perianal surgery. Eur J Anaesthesiol 2003;20:404–408. 122. Tan P-H, Kuo J-H, Liu K, et al: Efficacy of intrathecal neostigmine for the relief of postinguinal hemiorrhaphy pain. Acta Anaesthesiol Scand 2000;44:1056–1060. 123. Nakayama M, Kanaya N, Fujita S, et al: Effects of ephedrine on indocyanine green clearance during spinal anesthesia: Evaluation by the finger piece method. Anesth Analg 1993;77:947–949. 124. Zinn SE, Fairley HB, Glenn JD: Liver function in patients with mild alcoholic hepatitis, after enflurane, nitrous oxide-narcotic, and spinal anesthesia. Anesth Analg 1985;64:487–490. 125. IgarashiM,Kawana S, Iwasaki H, et al:Anesthetic management for a patientwith citrullinemia and liver cirrhosis.Masui 1995;44:96–99. 126. Fukuda T, Okutani R, Kono K, et al: Anesthetic management for cesarean section of a patient with transient diabetes insipidus and acute severe liver dysfunction. Masui 1993;42:1511–1516. 127. McNeillMJ, Bennet A: Use of regional anaesthesia in a patient with acute porphyria. Br J Anaesth 1990;64:371–373. 128. Consolo D, Ouardirhi Y, Wessels C, et al: Obstetrical anaesthesia and porphyrias. Ann Fr Anesth Reanim 2005;24:428–431. 129. Runciman WB, Mather LE, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition.III: Effects of general and spinal anaesthesia on regional blood flow and oxygen tensions. Br J Anaesth 1984;56:1247–1258. 130. Runciman WB, Mather LE, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition. IV: The effects of general and spinal anaesthesia on blood flow and cefoxitin disposition. Br J Anaesth 1985;57:1239–1247. 131. Runciman WB, Mather LE, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition. VI: Effects of general or subarachnoid anaesthesia on blood flow and chlormethiazole disposition. Br J Anaesth 1986; 58: 1308–1316. 132. Mather LE, RuncimanWB, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition. V: The effects of general and subarachnoid anaesthesia on blood flow and pethidine disposition. Br J Anaesth 1986;58:888–896. 133. Bigler D, Hjortso NC, Edstrom H, et al: Comparative effects of intrathecal bupivacaine and tetracaine on analgesia, cardiovascular function and plasma catecholamines. Acta Anaesthesiol Scand 1986;30:199–203. 134. Carpenter RL, Caplan RA, Brown DL, et al: Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992;76:906–916. 135. Tarkkila P, Isola J: A regression model for identifying patients at high risk of hypotension, bradycardia and nausea during spinal anesthesia. Acta Anaesthesiol Scand 1992;36:554–558. 136. Klasen J, Junger A, Hartmann B, et al: Differing incidences of relevant hypotension with combined spinal-epidural anesthesia and spinal anesthesia. Anesth Analg 2003;96:1491–1495. 137. Hartmann B, Junger A, Klasen J, et al: The incidence and risk factors for hypotension after spinal anesthesia induction: An analysis with automated data collection. Anesth Analg 2002;94:1521–1529. 138. Nishiyama T, Komatsu K, Hanaoka K: Comparison of hemodynamic and anesthetic effects of hyperbaric bupivacaine and tetracaine in spinal anesthesia. J Anesth 2003;17:218–222. 139. Rooke GA, Freund PR, Jacobson AF: Hemodynamic response and change in organ blood volume during spinal anesthesia in elderly men with cardiac disease. Anesth Analg 1997;85:99–105. 140. Shimosato S, Etsten BE: The role of the venous system in cardiocirculatory dynamics during spinal and epidural anesthesia in man. Anesthesiology 1969;30:619–628. 141. Anzai Y,NishikawaT:Heart rate responses to body tilt during spinal anesthesia. Anesth Analg 1991;73:385–390. 142. Bergenwald L,FreyschussU,KaijserL, et al:Cardiovascular response to spinal anaesthesia in elderly men: Effects of head-up tilt and dihydroergotamine administration. Clin Physiol 1981;1:453–460. 143. Caplan RA, Ward RJ, Posner K, et al: Unexpected cardiac arrest during spinal anesthesia: A closed claims analysis of predisposing factors. Anesthesiology 1988;68:5–11. 144. Bernards CM, Hymas NJ: Progression of first degree heart block to high-grade second degree block during spinal anaesthesia. Can J Anaesth 1992;39:173–175. 145. Graves CL,Underwood PS, Klein RL, et al: Intravenous fluid administration as therapy for hypotension secondary to spinal anesthesia. Anesth Analg 1968;47:548–556. 146. Venn PJ, Simpson DA, Rubin AP, et al: Effect of fluid preloading on cardiovascular variables after spinal anaesthesia with glucose-free 0.75% bupivacaine. Br J Anaesth 1989;63:682–687. 147. Coe AJ, Revanas B: Is crystalloid preloading useful in spinal anaesthesia in the elderly? Anaesthesia 1990;45:241–243. 148. Butterworth JF 4th, PiccioneWJr, Berrizbeitia LD, et al: Augmentation of venous return by adrenergic agonists during spinal anesthesia. Anesth Analg 1986;65:612–616. 149. Ward RJ, Kennedy WF, Bonica JJ, et al: Experimental evaluation of atropine and vasopressors for the treatment of hypotension of high subarachnoid anesthesia. Anesth Analg 1966;45:621–629. 150. Sidi A, Pollak D, Floman Y, et al: Hypobaric spinal anesthesia in the operative management of orthopedic emergencies in geriatric patients. Isr J Med Sci 1984;20:589–592. 151. Sinclair CJ, Scott DB, Edstrom HH: Effect of the Trendelenberg position on spinal anaesthesia with hyperbaric bupivacaine. Br J Anaesth 1982;54:497–500. 152. Ou CH, Tsou MY, Ting CK, et al: Occurrence of the Bezold-Jarisch reflex during Cesarean section under spinal anesthesia–a case report. Acta Anaesthesiol Taiwan 2004;42:175–178. 153. Mackey DC, Carpenter RL, Thompson GE, et al: Bradycardia and asystole during spinal anesthesia: A report of three cases without morbidity. Anesthesiology 1989;70:866–868. 154. Campagna JA, Carter C: Clinical relevance of the Bezold–Jarisch reflex. Anesthesiology 2003;98:1250–1260. 155. Lesser JB, Sanborn KV, Valskys R, et al: Severe bradycardia during spinal and epidural anesthesia recorded by an anesthesia information management system. Anesthesiology 2003;99:859–866. 156. Kinsella SM, Tuckey JP: Perioperative bradycardia and asystole: Relationship to vasovagal syncope and the Bezold–Jarisch reflex. Br J Anaesth 2001;86:859–868. 157. Greene NM, Brull SJ: Physiology of Spinal Anesthesia, 4th ed. Williams &Wilkins, 1981. 158. Steinbrook RA, Concepcion M, Topulos GP: Ventilatory responses to hypercapnia during bupivacaine spinal anesthesia. Anesth Analg 1988;67:247–252. 159. Schneider MC, HolzgreveW: 100 years ago: Oskar Kreis, a pioneer in spinal obstetric analgesia at the University Women’s Clinic of Basel. Anaesthesist 2001;50:525–528. 160. Taivainen T, Tuominen M, Rosenberg PH: Influence of obesity on the spread of spinal analgesia after injection of plain 0.5% bupivacaine at the L3-4 or L4-5 interspace. Br J Anaesth 1990;64:542–546. 161. Tuominen M, Taivainen T, Rosenberg PH: Spread of spinal anaesthesia with plain 0.5% bupivacaine: Influence of the vertebral interspace used for injection. Br J Anaesth 1989;62:358–361. 162. Tuominen M, Kuulasmaa K, Taivainen T, et al: Individual predictability of repeated spinal anaesthesia with isobaric bupivacaine. Acta Anaesthesiol Scand 1989;33:13–14. 163. Sundnes KO, Vaagenes P, Skretting P, et al: Spinal analgesia with hyperbaric bupivacaine: Effects of volume of solution. Br J Anaesth 1982;54:69–74. 164. Konishi R,Mitsuhata H, Saitoh J, et al: The spread of subarachnoid hyperbaric dibucaine in the term parturient. Masui 1997;46:184–187. 165. Veering BT, Ter Riet PM, Burm AG, et al: Spinal anaesthesia with 0.5% hyperbaric bupivacaine in elderly patients: Effect of site of injection on spread of analgesia. Br J Anaesth 1996;77:343–346. 166. Cameron AE,Arnold RW, GhorisaMW, et al: Spinal analgesia using bupivacaine 0.5% plain. Variation in the extent of the block with patient age. Anaesthesia 1981;36:318–322. 167. Pitkanen M, Haapaniemi L, Tuominen M, et al: Influence of age on spinal anaesthesia with isobaric 0.5% bupivacaine. Br J Anaesth 1984;56:279–284. 168. Veering BT, BurmAG, Vletter AA, et al: The effect of age on systemic absorption and systemic disposition of bupivacaine after subarachnoid administration. Anesthesiology 1991;74:250–257. 169. Racle JP, BenkhadraA, Poy JY, et al: Spinal analgesiawith hyperbaric bupivacaine: Influence of age. Br J Anaesth 1988;60:508–514. 170. Schiffer E, Van Gessel E, Gamulin Z: Influence of sex on cerebrospinal fluid density in adults. Br J Anaesth 1999;83:943–944. 171. ParggerH,HamplKF,AeschbachA, et al:Combinedeffectof patient variables on sensory level after spinal 0.5% plain bupivacaine. Acta Anaesthesiol Scand 1998;42:430–434. 172. Povey HM, Jacobsen J, Westergaard-Nielsen J: Subarachnoid analgesia with hyperbaric 0.5% bupivacaine: Effect of a 60-min period of sitting. Acta Anaesthesiol Scand 1989;33:295–297. 173. Alston RP, Littlewood DG, Meek R, et al: Spinal anesthesia with hyperbaric bupivacaine: Effects of concentration and volume when administered in the sitting position. Br J Anaesth 1988;61:144–148. 174. Alston RP: Spinal anaesthesia with 0.5% bupivacaine 3 mL: Comparison of plain and hyperbaric solutions administered to seated patients. Br J Anaesth 1988;61:385–389. 175. Mitchell RW, Bowler GM, Scott DB, et al: Effects of posture and baricity on spinal anaesthesia with 0.5% bupivacaine 5 ml. A double-blind study. Br J Anaesth 1988;61:139–143. 176. PoveyHM,Olsen PA, Pihl H: Spinal analgesiawith hyperbaric 0.5% bupivacaine: effects of different patient positions.ActaAnaesthesiol Scand 1987;31:616–619.
Rate this article |
Comments (0 posted)
Post your comment